Creo Medical (UK) Insiders

Creo Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.201) % which means that it has lost $0.201 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3849) %, meaning that it generated substantial loss on money invested by shareholders. Creo Medical's management efficiency ratios could be used to measure how well Creo Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Creo Medical's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 46.7 M in 2025, whereas Total Current Assets are likely to drop slightly above 32.9 M in 2025. Common Stock Shares Outstanding is likely to gain to about 378 M in 2025, despite the fact that Net Loss is likely to grow to (21 M).

Creo Medical Workforce Comparison

The company has Profit Margin (PM) of (0.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.89) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.89.

Creo Medical Group Benchmark Summation

Creo Medical Notable Stakeholders

The success or failure of an entity such as Creo Medical Group often depends on how effective the management is. Creo Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Creo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Creo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Creo Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Creo Medical Group. Check Creo Medical's Beneish M Score to see the likelihood of Creo Medical's management manipulating its earnings.

When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.